Pulmonx
LUNG1.61028.80% ( +0.360 )
Pulmonx (LUNG)
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of ch...
- Open
- 1.400
- High
- 1.810
- Low
- 1.325
- Prev. Close
- 1.250
- Volume
- 4.81M
- Turnover
- 8.11M
- Avg Price
- 1.685
- Bid/Ask Ratio
- --
- Amplitude
- 38.80%
- 52wk High
- 3.390
- Volume Ratio
- 15.15
- Turnover Ratio
- 13.02%
Pulmonx Analyst Rating
View MoreForecast & Rating
Jul 30, 2026Price forecast
$3.40111.18%
Forecast & RatingBuy
5analysts
- Strong buy60.00%
- Buy0.00%
- Hold40.00%
- Sell0.00%
- Strong sell0.00%
News
- rttnews · 3 hours ago
Top Biotech Gainers: GCTK On The Move, BHC, CORT Boost FY'26 Outlook, NEOG On Watch
- benzinga_article · 13 hours ago
12 Health Care Stocks Moving In Thursday's Intraday Session
- Tip Ranks · 19 hours ago
Piper Sandler Remains a Hold on Pulmonx (LUNG)
- MSN · 23 hours ago
Shell in charts: Q2 revenue ticks higher across major segments
- benzinga_article · 1 day ago, 03:48 PM
Pulmonx shares are trading lower after the company announced an offering.
- benzinga_article · 1 day ago, 03:48 PM
Pulmonx shares are trading higher after the company reported better-than-expected Q2 financial results.
